WallStreetZenWallStreetZen

NASDAQ: IKT
Inhibikase Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for IKT

Based on 1 analyst offering 12 month price targets for Inhibikase Therapeutics Inc.
Min Forecast
$27.00+1,185.71%
Avg Forecast
$27.00+1,185.71%
Max Forecast
$27.00+1,185.71%

Should I buy or sell IKT stock?

Based on 1 analyst offering ratings for Inhibikase Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IKT stock forecasts and price targets.

IKT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-07

1 of 1

IKT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IKT$2.10$27.00+1,185.71%Buy
KPRX$0.51$2.00+292.16%Buy
EDSA$4.36$21.00+381.65%Buy
NNVC$1.18$6.50+453.19%Strong Buy
XTLB$2.44N/AN/A

Inhibikase Therapeutics Stock Forecast FAQ

Is Inhibikase Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IKT) stock is to Buy IKT stock.

Out of 1 analyst, 0 (0%) are recommending IKT as a Strong Buy, 1 (100%) are recommending IKT as a Buy, 0 (0%) are recommending IKT as a Hold, 0 (0%) are recommending IKT as a Sell, and 0 (0%) are recommending IKT as a Strong Sell.

If you're new to stock investing, here's how to buy Inhibikase Therapeutics stock.

What is IKT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IKT price target, the average IKT price target is $27.00, with the highest IKT stock price forecast at $27.00 and the lowest IKT stock price forecast at $27.00.

The Wall Street analyst predicted that Inhibikase Therapeutics's share price could reach $27.00 by Mar 7, 2025. The average Inhibikase Therapeutics stock price prediction forecasts a potential upside of 1,185.71% from the current IKT share price of $2.10.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.